314 related articles for article (PubMed ID: 15556610)
1. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Kang SK; Lee JY; Chung TW; Kim CH
FEBS Lett; 2004 Nov; 577(3):361-6. PubMed ID: 15556610
[TBL] [Abstract][Full Text] [Related]
2. Disialoganglioside GD3 synthase expression recruits membrane transglutaminase 2 during erythroid differentiation of the human chronic myelogenous leukemia K562 cells.
Kang SK; Kim YS; Kong YJ; Song KH; Chang YC; Park YG; Ko JH; Lee YC; Kim CH
Proteomics; 2008 Aug; 8(16):3317-28. PubMed ID: 18690648
[TBL] [Abstract][Full Text] [Related]
3. Induction of GD3/α1-adrenergic receptor/transglutaminase 2-mediated erythroid differentiation in chronic myelogenous leukemic K562 cells.
Ha SH; Kang SK; Choi H; Kwak CH; Abekura F; Park JY; Kwon KM; Chang HW; Lee YC; Ha KT; Hou BK; Chung TW; Kim CH
Oncotarget; 2017 Sep; 8(42):72205-72219. PubMed ID: 29069780
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
5. Militarinone A induces differentiation in PC12 cells via MAP and Akt kinase signal transduction pathways.
Riese U; Ziegler E; Hamburger M
FEBS Lett; 2004 Nov; 577(3):455-9. PubMed ID: 15556627
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
7. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
8. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
Kucukkaya B; Arslan DO; Kan B
Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
[TBL] [Abstract][Full Text] [Related]
9. The putative morphogen, DIF-1, of Dictyostelium discoideum activates Akt/PKB in human leukemia K562 cells.
Kubohara Y; Hosaka K
Biochem Biophys Res Commun; 1999 Oct; 263(3):790-6. PubMed ID: 10512759
[TBL] [Abstract][Full Text] [Related]
10. Role of ERK activation in growth and erythroid differentiation of K562 cells.
Woessmann W; Mivechi NF
Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
[TBL] [Abstract][Full Text] [Related]
11. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells.
Kang CD; Do IR; Kim KW; Ahn BK; Kim SH; Chung BS; Jhun BH; Yoo MA
Exp Mol Med; 1999 Jun; 31(2):76-82. PubMed ID: 10410306
[TBL] [Abstract][Full Text] [Related]
12. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
13. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
[TBL] [Abstract][Full Text] [Related]
14. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
15. ETV6 Regulates Hemin-Induced Erythroid Differentiation of K562 Cells through Mediating the Raf/MEK/ERK Pathway.
Li Z; Sun MZ; Lv X; Guo C; Liu S
Biol Pharm Bull; 2022; 45(3):250-259. PubMed ID: 35228392
[TBL] [Abstract][Full Text] [Related]
16. Nuclear translocation of active AKT is required for erythroid differentiation in erythropoietin treated K562 erythroleukemia cells.
Missiroli S; Etro D; Buontempo F; Ye K; Capitani S; Neri LM
Int J Biochem Cell Biol; 2009 Mar; 41(3):570-7. PubMed ID: 18694847
[TBL] [Abstract][Full Text] [Related]
17. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development.
Burchert A; Wang Y; Cai D; von Bubnoff N; Paschka P; Müller-Brüsselbach S; Ottmann OG; Duyster J; Hochhaus A; Neubauer A
Leukemia; 2005 Oct; 19(10):1774-82. PubMed ID: 16136169
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
[TBL] [Abstract][Full Text] [Related]
19. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
Algarni AS; Hargreaves AJ; Dickenson JM
Eur J Pharmacol; 2018 Feb; 820():113-129. PubMed ID: 29242118
[TBL] [Abstract][Full Text] [Related]
20. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.
Jacquel A; Herrant M; Legros L; Belhacene N; Luciano F; Pages G; Hofman P; Auberger P
FASEB J; 2003 Nov; 17(14):2160-2. PubMed ID: 14597677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
